Therefore, further characterizing the regulators and effectors for this key lipid enzyme family and its lipid product PA will not only provide novel insights into the PLD-PA lipid pathway in normal physiology but also reveal potential therapeutic targets for treating human diseases like cancer. This evidence concerns the gene GPLD1 and cancer.